|
|
???tair.name??? >
???browser.page.title.title???
|
Showing items 692781-692790 of 2349123 (234913 Page(s) Totally)
<< < 69274 69275 69276 69277 69278 69279 69280 69281 69282 69283 > >>
View [10|25|50] records per page
| 國家衛生研究院 |
2019-09 |
Prognostic and clinicopathologic associations of Casein Kinase (CK) 1 alpha in acral lentiginous melanoma
|
Chang, C;Huang, S;Ito, T;Lo, Y;Shen, C;Tsai, K;Wu, T;Hsu, Y;Chang, K;Lin, T |
| 輔英科技大學 |
2011/03 |
Prognostic and Molecular Factors in Stage II Colorectal Cancer
|
Yung-Sung Yeh; Hwei-Ming Wang; Shiu-Ru Lin; Jaw-Yuan Wang |
| 國立臺灣大學 |
2010 |
Prognostic and Predictive Values of E-Cadherin for Patients of Ovarian Clear Cell Adenocarcinoma
|
何志明; 鄭文芳; 林明杰; 黃世鴻; 劉復興; 張簡展照; 余慕賢; 王道遠; 謝長堯; HO, CHIH-MING; CHENG, WEN-FANG; LIN, MING-CHIEH; HUANG, SHIH-HUNG; LIU, FU-SHING; CHANG, CHIEN CHAN- CHAO; YU, MU-HSIEN; WANG, TAO-YEUAN; HSIEH, CHANG- YAO; HSIEH, CHANG-YAO |
| 臺大學術典藏 |
2020-02-06T05:22:13Z |
Prognostic and predictive values of e-cadherin for patients of ovarian clear cell adenocarcinoma
|
Liu F.-S.;Huang S.-H.;Chen T.-C.;Lin M.-C.;Hsieh C.-Y.;WEN-FANG CHENG;Ho C.-M.;Ho C.-M.;Ho C.-M.; Ho C.-M.; Ho C.-M.; Ho C.-M.; WEN-FANG CHENG; Hsieh C.-Y.; Lin M.-C.; Chen T.-C.; Huang S.-H.; Liu F.-S.; Ho C.-M.; Ho C.-M.; Ho C.-M.; WEN-FANG CHENG; Hsieh C.-Y.; Lin M.-C.; Chen T.-C.; Huang S.-H.; Liu F.-S. |
| 臺大學術典藏 |
2020-02-14T02:50:00Z |
Prognostic and predictive values of e-cadherin for patients of ovarian clear cell adenocarcinoma
|
Ho C.-M.;Ho C.-M.;Ho C.-M.;Wen-Fang Cheng;Hsieh C.-Y.;Lin M.-C.;Chen T.-C.;Huang S.-H.;Liu F.-S.; Ho C.-M.; WEN-FANG CHENG; Hsieh C.-Y.; Lin M.-C.; Chen T.-C.; Huang S.-H.; Liu F.-S. |
| 臺大學術典藏 |
2020-11-27T08:14:21Z |
Prognostic and predictive values of e-cadherin for patients of ovarian clear cell adenocarcinoma
|
Ho C.-M.;Ho C.-M.;Ho C.-M.;Cheng W.-F.;Chang-Yao Hsieh;Lin M.-C.;Chen T.-C.;Huang S.-H.;Liu F.-S.; Ho C.-M.; Ho C.-M.; Ho C.-M.; Cheng W.-F.; CHANG-YAO HSIEH; Lin M.-C.; Chen T.-C.; Huang S.-H.; Liu F.-S. |
| 國家衛生研究院 |
2014-02 |
Prognostic and therapeutic impact of argininosuccinate synthetase 1 control in bladder cancer as monitored longitudinally by PET imaging
|
Allen, MD;Luong, P;Hudson, C;Leyton, J;Delage, B;Ghazaly, E;Cutts, R;Yuan, M;Syed, N;Lo Nigro, C;Lattanzio, L;Chmielewska-Kassassir, M;Tomlinson, I;Roylance, R;Whitaker, HC;Warren, AY;Neal, D;Frezza, C;Beltran, L;Jones, LJ;Chelala, C;Wu, BW;Bomalaski, JS;Jackson, RC;Lu, YJ;Crook, T;Lemoine, NR;Mather, S;Foster, J;Sosabowski, J;Avril, N;Li, CF;Szlosarek, PW |
| 臺北醫學大學 |
2016-01 |
Prognostic Benefits of Carvedilol, Bisoprolol, and Metoprolol Controlled Release/Extended Release in Hemodialysis Patients with Heart Failure: A 10-Year Cohort
|
蘇裕謀; Chao-Hsiun Tang, Chia-Chen Wang, Tso-Hsiao Chen, Chuang-Ye Hong, Yuh-Mou Sue |
| 臺大學術典藏 |
2021-11-03T05:24:54Z |
Prognostic Characteristics and Immunotherapy Response of Patients With Nonsquamous NSCLC With Kras Mutation in East Asian Populations: A Single-Center Cohort Study in Taiwan
|
Wu S.-G.; Liao W.-Y.; Su K.-Y.; Yu S.-L.; Huang Y.-L.; CHONG-JEN YU; Chih-Hsin Yang J.; Shih J.-Y. |
| 臺大學術典藏 |
2022-08-10T02:37:41Z |
Prognostic Characteristics and Immunotherapy Response of Patients With Nonsquamous NSCLC With Kras Mutation in East Asian Populations: A Single-Center Cohort Study in Taiwan
|
Wu S.-G.; Liao W.-Y.; Su K.-Y.; Yu S.-L.; Huang Y.-L.; Yu C.-J.; CHIH-HSIN YANG; Shih J.-Y. |
Showing items 692781-692790 of 2349123 (234913 Page(s) Totally)
<< < 69274 69275 69276 69277 69278 69279 69280 69281 69282 69283 > >>
View [10|25|50] records per page
|
